Top

Published in:

01-03-2011 | Review article

A review of African American-white differences in risk factors for cancer: prostate cancer

Authors: Irina Mordukhovich, Paul L. Reiter, Danielle M. Backes, Leila Family, Lauren E. McCullough, Katie M. O’Brien, Hilda Razzaghi, Andrew F. Olshan

Published in: Cancer Causes & Control | Issue 3/2011

Abstract

Objective

African American men have higher prostate cancer incidence rates than White men, for reasons not completely understood. This review summarizes the existing literature of race-specific associations between risk factors and prostate cancer in order to examine whether associations differ.

Methods

We reviewed epidemiologic studies published between January 1970 and December 2008 that reported race-specific effect estimates. We focused mainly on modifiable risk factors related to lifestyle and health. A total of 37 articles from 21 study populations met our inclusion criteria.

Results

We found no evidence of racial differences in associations between prostate cancer and alcohol intake, tobacco use, and family history of prostate cancer. Research suggests that a modest positive association may exist between height and prostate cancer risk (all prostate cancer and advanced prostate cancer) among Whites only. No clear patterns were observed for associations with physical activity, weight/body mass index, dietary factors, occupational history, sexual behavior, sexually transmissible infections, and other health conditions.

Discussion

Our results suggest few differences in prostate cancer risk factors exist between racial groups and underscore areas where additional research is needed. Future studies should enroll higher numbers of African American participants and report results for advanced prostate cancer.

Available only for authorised users

American Cancer Society (2010) Cancer facts & figures 2010. American Cancer Society, Atlanta

Horner MJ, Ries LAG, Krapcho M et al. (2009) SEER cancer statistics review, 1975–2006, National Cancer Institute. Bethesda, MD. Based on November 2008 SEER data submission, posted to the SEER web site. Available from: http://seer.cancer.gov/csr/1975_2006/

American Cancer Society (2009) Cancer facts & figures for African Americans 2009–2010. American Cancer Society, Atlanta

American Cancer Society (2009) Cancer facts & figures 2009. American Cancer Society, Atlanta

Williams H, Powell IJ (2009) Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol Biol 472:439–453CrossRefPubMed

Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990) Family history and the risk of prostate cancer. Prostate 17:337–347CrossRefPubMed

Crawford ED (2003) Epidemiology of prostate cancer. Urology 62:3–12CrossRefPubMed

Gronberg H (2003) Prostate cancer epidemiology. Lancet 361:859–864CrossRefPubMed

Yu H, Harris RE, Wynder EL (1988) Case–control study of prostate cancer and socioeconomic factors. Prostate 13:317–325CrossRefPubMed

10.

Hayes RB, Ziegler RG, Gridley G et al (1999) Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev 8:25–34PubMed

11.

Habel LA, Van Den Eeden SK, Friedman GD (2000) Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate 43:136–143CrossRefPubMed

12.

Sanderson M, Coker AL, Logan P, Zheng W, Fadden MK (2004) Lifestyle and prostate cancer among older African-American and Caucasian men in South Carolina. Cancer Causes Control 15:647–655CrossRefPubMed

13.

Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr (2004) Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15:35–43CrossRefPubMed

14.

Tsai CJ, Cohn BA, Cirillo PM, Feldman D, Stanczyk FZ, Whittemore AS (2006) Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States). Cancer Causes Control 17:1237–1244CrossRefPubMed

15.

Beebe-Dimmer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA (2007) Features of the metabolic syndrome and prostate cancer in African-American men. Cancer 109:875–881CrossRefPubMed

16.

Whittemore AS, Kolonel LN, Wu AH et al (1995) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87:652–661CrossRefPubMed

17.

Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE (1987) Case–control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 78:869–874PubMed

18.

Hayes RB, Pottern LM, Swanson GM et al (1994) Tobacco use and prostate cancer in blacks and whites in the United States. Cancer Causes Control 5:221–226CrossRefPubMed

19.

Hayes RB, Brown LM, Schoenberg JB et al (1996) Alcohol use and prostate cancer risk in US blacks and whites. Am J Epidemiol 143:692–697PubMed

20.

Clarke G, Whittemore AS (2000) Prostate cancer risk in relation to anthropometry and physical activity: the National health and nutrition examination survey I epidemiological follow-up study. Cancer Epidemiol Biomarkers Prev 9:875–881PubMed

21.

Rosenberg DJ, Neugut AI, Ahsan H, Shea S (2002) Diabetes mellitus and the risk of prostate cancer. Cancer Invest 20:157–165CrossRefPubMed

22.

Coker AL, Sanderson M, Zheng W, Fadden MK (2004) Diabetes mellitus and prostate cancer risk among older men: population-based case–control study. Br J Cancer 90:2171–2175PubMed

23.

Darbinian JA, Ferrara AM, Van Den Eeden SK, Quesenberry CP Jr, Fireman B, Habel LA (2008) Glycemic status and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 17:628–635CrossRefPubMed

24.

Friedman GD (1997) Blood pressure and heart rate: no evidence for a positive association with prostate cancer. Ann Epidemiol 7:486–489CrossRefPubMed

25.

Habel LA, Zhao W, Stanford JL (2002) Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control 13:427–434CrossRefPubMed

26.

Govindarajan R, Ratnasinghe L, Simmons DL et al (2007) Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol 25:1476–1481CrossRefPubMed

27.

Hawk E, Breslow RA, Graubard BI (2000) Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 9:523–527PubMed

28.

Patel DA, Bock CH, Schwartz K, Wenzlaff AS, Demers RY, Severson RK (2005) Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case–control study in Wayne County, Michigan. Cancer Causes Control 16:263–273CrossRefPubMed

29.

Kolonel LN, Hankin JH, Whittemore AS et al (2000) Vegetables, fruits, legumes and prostate cancer: a multiethnic case–control study. Cancer Epidemiol Biomarkers Prev 9:795–804PubMed

30.

Vogt TM, Mayne ST, Graubard BI et al (2002) Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol 155:1023–1032CrossRefPubMed

31.

Vogt TM, Ziegler RG, Graubard BI et al (2003) Serum selenium and risk of prostate cancer in US blacks and whites. Int J Cancer 103:664–670CrossRefPubMed

32.

Rodriguez C, McCullough ML, Mondul AM et al (2006) Meat consumption among Black and White men and risk of prostate cancer in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 15:211–216CrossRefPubMed

33.

Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN (2007) Fat and meat intake and prostate cancer risk: the multiethnic cohort study. Int J Cancer 121:1339–1345CrossRefPubMed

34.

Hayes RB, Liff JM, Pottern LM et al (1995) Prostate cancer risk in US blacks and whites with a family history of cancer. Int J Cancer 60:361–364CrossRefPubMed

35.

Whittemore AS, Wu AH, Kolonel LN et al (1995) Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 141:732–740PubMed

36.

Cunningham GR, Ashton CM, Annegers JF, Souchek J, Klima M, Miles B (2003) Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate 56:256–262CrossRefPubMed

37.

Beebe-Dimmer JL, Drake EA, Dunn RL, Bock CH, Montie JE, Cooney KA (2006) Association between family history of prostate and breast cancer among African-American men with prostate cancer. Urology 68:1072–1076CrossRefPubMed

38.

Krstev S, Baris D, Stewart P et al (1998) Occupational risk factors and prostate cancer in US blacks and whites. Am J Ind Med 34:421–430CrossRefPubMed

39.

Meyer TE, Coker AL, Sanderson M, Symanski E (2007) A case–control study of farming and prostate cancer in African-American and Caucasian men. Occup Environ Med 64:155–160CrossRefPubMed

40.

Hayes RB, Pottern LM, Greenberg R et al (1993) Vasectomy and prostate cancer in US blacks and whites. Am J Epidemiol 137:263–269PubMed

41.

John EM, Whittemore AS, Wu AH et al (1995) Vasectomy and prostate cancer: results from a multiethnic case–control study. J Natl Cancer Inst 87:662–669CrossRefPubMed

42.

Wideroff L, Schottenfeld D, Carey TE et al (1996) Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate 28:117–123CrossRefPubMed

43.

Hayes RB, Pottern LM, Strickler H et al (2000) Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 82:718–725CrossRefPubMed

44.

Jenkins FJ, Hayes RB, Jackson A et al (2007) Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis 196:208–211CrossRefPubMed

45.

Huang WY, Hayes R, Pfeiffer R et al (2008) Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17:2374–2381CrossRefPubMed

46.

Powell IJ (2007) Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 177:444–449CrossRefPubMed

47.

Wallace TA, Prueitt RL, Yi M et al (2008) Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res 68:927–936CrossRefPubMed

48.

Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241CrossRefPubMed

49.

Zuccolo L, Harris R, Gunnell D et al (2008) Height and prostate cancer risk: a large nested case–control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev 17:2325–2336CrossRefPubMed

50.

Pinsky PF, Ford M, Gamito E et al (2008) Enrollment of racial and ethnic minorities in the prostate, lung, colorectal and ovarian cancer screening trial. J Natl Med Assoc 100:291–298PubMed

51.

Lai GY, Gary TL, Tilburt J et al (2006) Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clin Trials 3:133–141CrossRefPubMed

52.

Fowke JH, Signorello LB, Underwood W 3rd, Ukoli FA, Blot WJ (2006) Obesity and prostate cancer screening among African-American and Caucasian men. Prostate 66:1371–1380CrossRefPubMed

53.

Jacobsen PB, Lamonde LA, Honour M, Kash K, Hudson PB, Pow-Sang J (2004) Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology 13:80–85CrossRefPubMed

54.

Howards SS, Peterson HB (1993) Vasectomy and prostate cancer. Chance, bias, or a causal relationship? JAMA 269:913–914CrossRefPubMed

55.

Molenaar EA, Van Ameijden EJ, Grobbee DE, Numans ME (2007) Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project. Eur J Public Health 17:199–205CrossRefPubMed

56.

Murff HJ, Spigel DR, Syngal S (2004) Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 292:1480–1489CrossRefPubMed

57.

Gaff CL, Aragona C, MacInnis RJ et al (2004) Accuracy and completeness in reporting family history of prostate cancer by unaffected men. Urology 63:1111–1116CrossRefPubMed

58.

Fendrich M, Mackesy-Amiti ME, Johnson TP, Hubbell A, Wislar JS (2005) Tobacco-reporting validity in an epidemiological drug-use survey. Addict Behav 30:175–181CrossRefPubMed

59.

Etzioni R, Berry KM, Legler JM, Shaw P (2002) Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991–1998. Urology 59:251–255CrossRefPubMed

60.

Ross LE, Berkowitz Z, Ekwueme DU (2008) Use of the prostate-specific antigen test among US men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 17:636–644CrossRefPubMed

61.

Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300CrossRefPubMed

62.

Draisma G, Etzioni R, Tsodikov A et al (2009) Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 101:374–383CrossRefPubMed

Title: A review of African American-white differences in risk factors for cancer: prostate cancer
Authors: Irina Mordukhovich
Paul L. Reiter
Danielle M. Backes
Leila Family
Lauren E. McCullough
Katie M. O’Brien
Hilda Razzaghi
Andrew F. Olshan
Publication date: 01-03-2011
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 3/2011
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-010-9712-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 3/2011

Has the lung cancer risk from smoking increased over the last fifty years?

Papillary thyroid cancer incidence rates vary significantly by birthplace in Asian American women

Cohorts and consortia conference: a summary report (Banff, Canada, June 17–19, 2009)

Reproductive history and risk of three breast cancer subtypes defined by three biomarkers

Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers

Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer